» Articles » PMID: 39794554

Structure and Catalytic Mechanism of Exogenous Fatty Acid Recycling by AasS, a Versatile Acyl-ACP Synthetase

Overview
Date 2025 Jan 10
PMID 39794554
Authors
Affiliations
Soon will be listed here.
Abstract

Fatty acids (FAs) are essential building blocks for all the domains of life, of which bacterial de novo synthesis, called type II FA synthesis (FAS II), is energetically expensive. The recycling of exogenous FAs (eFAs) partially relieves the FAS II demand and, therefore, compromises the efficacy of FAS II-directed antimicrobials. The versatile acyl-acyl carrier protein (ACP) synthetase, AasS, enables bacterial channeling of diverse eFA nutrients through holo-ACP, an activated form of ACP. However, the molecular mechanism for AasS catalysis is not fully understood. Here we report a series of cryo-electron microscopy structures of AasS from the bioluminescent bacterium Vibrio harveyi to provide insights into the catalytic cycle. AasS forms a ring-shaped hexamer, with each protomer folding into two distinct domains. Biochemical and structural analysis suggests that AasS accommodates distinct eFA substrates and the conserved W230 residue has a gating role. Adenosine triphosphate and Mg binding converts the AasS hexamer to a tetramer, which is likely needed for the acyl adenylate intermediate formation. Afterward, AasS reverts to the hexamer conformation in adaption to acyl-ACP production. The complete landscape for eFA scavenging lays a foundation for exploiting the versatility of AasS in biopharmaceuticals.

References
1.
Radka C, Rock C . Mining Fatty Acid Biosynthesis for New Antimicrobials. Annu Rev Microbiol. 2022; 76:281-304. PMC: 9463108. DOI: 10.1146/annurev-micro-041320-110408. View

2.
Parsons J, Rock C . Bacterial lipids: metabolism and membrane homeostasis. Prog Lipid Res. 2013; 52(3):249-76. PMC: 3665635. DOI: 10.1016/j.plipres.2013.02.002. View

3.
Yao J, Rock C . How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics. J Biol Chem. 2015; 290(10):5940-6. PMC: 4358231. DOI: 10.1074/jbc.R114.636241. View

4.
Campbell J, Cronan Jr J . Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol. 2001; 55:305-32. DOI: 10.1146/annurev.micro.55.1.305. View

5.
Balemans W, Lounis N, Gilissen R, Guillemont J, Simmen K, Andries K . Essentiality of FASII pathway for Staphylococcus aureus. Nature. 2010; 463(7279):E3. DOI: 10.1038/nature08667. View